Strand AI
Multimodal foundation models to predict uncollected patient biology
À propos
Description de l’entreprise en anglais
Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
Thèmes
HealthcareDrug Discovery and Delivery
- Localisation
- San Francisco, CA, États-Unis
- Équipe
- 2 employés
- Promotion YC
- Winter 2026
- Statut
- Active
- Stade
- Phase d’amorçage
